MedPath
TGA Approval

HEPCLUDEX bulevirtide (as acetate) 2 mg powder for injection vial (407179)

407179

HEPCLUDEX bulevirtide (as acetate) 2 mg powder for injection vial

Gilead Sciences Pty Ltd

July 30, 2024

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/209d867b84927fadffee084b6020de99.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/c44141fe3ef440aed1bf2f016d73e60e.pdf

Active Ingredients

bulevirtide acetate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

HEPCLUDEX bulevirtide (as acetate) 2 mg powder for injection vial (407179) - TGA 批准文号 | MedPath